Related by context. All words. (Click for frequent words.) 60 Attained 58 Achieves 56 Demonstrated 55 Surpassed 55 achieved 54 Generated 53 Exceeded 53 Maintained 52 Achievable 51 Resulted 51 Increase 51 Awarded 51 More Than Doubled 51 Received 51 Achieves Record 51 Exceeds 51 Facilitates 50 Boasts 50 Sequential Growth 50 Quadrupled 50 #/#.# #/#.# [001] 50 Highest Percentage 50 Achieve 50 Accomplishes 50 Primary Endpoint 49 Consecutive Quarters 49 Improve 49 Achieves Milestone 49 Improves 49 Achieves Positive 49 Significantly Reduced 49 Produces 49 Quadruples 49 Cash Flow Positive 49 Anticipates Record 49 Achieving 49 Rewarded 49 Generates Record 49 Sustains 49 Significantly Improved 48 Operational Highlights 48 Exceed Expectations 48 Generates 48 Milestone Reached 48 Chalks Up 48 Pinnacle Digest Opinions Requested 48 Highest Ever 48 Delivers 48 Fifth Consecutive 48 Carried Out 48 Attains 47 Surpasses 47 Clinical Remission 47 Impacting 47 Third Consecutive Quarter 47 Exceeds Expectations 47 Revenues Increase 47 Outperformed 47 Pacific Rubiales Announces 47 Survival Benefit 47 Achieves Record Revenue 47 Survival Rate 47 Demonstrated Significant 47 Significant Milestone 47 Positive Cash Flow 47 Revenue Grows 47 Results Confirm 47 Lupus Drug 47 Significantly Improve 47 Translate Into 47 Significantly Increases 47 Demonstrates Significant 47 Dramatically Increases 47 Contributes 47 Reduced Costs 47 Anticipates 47 Reported 47 GT Solar Receives 47 Nearly Doubled 47 Profitable Quarter 47 Achieves Record Sales 47 Market Penetration 47 Reaches 47 Fourfold 47 Rate Drops 47 Study Demonstrates 47 Exceeded Expectations 47 Helps Improve 47 Results Reflect 47 Pursues 47 Contracts Awarded 47 Substantial Increase 47 Bodes Well 47 Less Than 47 Million Ounces 46 Improves Outcomes 46 Maximizes 46 Six Months 46 Momentum Continues 46 Achieves Highest 46 Accounted 46 Has Achieved 46 Significantly Reduces 46 Rolled Out 46 Readied 46 Continues Momentum 46 Higher Than 46 Significantly Expand 46 Fifth Consecutive Quarter 46 Realizes 46 Significant Increase 46 Record Levels 46 Improves Quality 46 Achieve Significant 46 Evaluated 46 INTEGRILIN R eptifibatide Injection 46 Opportunities Exist 46 Record Setting 46 Subsidiary Receives 46 Significant Improvements 46 Implant Sciences Receives 46 Doubled 46 Ensured 46 Cocaine Seizure 46 Accelerates 46 BioSante Pharmaceuticals Reports 46 Statistically Significant 46 Surpass 46 Per Cent Increase 46 Results Indicate 46 Record Breaking 46 Commenced 46 Earns 46 Order Intake 46 Underscore Need 46 Cheaper Than 46 Less Than Half 46 Cost Efficiencies 46 Study Proves 46 Dramatic Increase 46 Racks Up 46 Facilitate 46 Significant Milestones 46 Significant Reduction 46 Permits Issued 46 Secures 46 Kerastick ® 46 Outstrip 46 Demonstrate 46 Phase III Clinical Trial 46 Reaches Record 46 Helps Ensure 46 Reprices 46 Sees Continued Growth 46 Surpass Expectations 46 Rank Highest 46 Avoided 46 Positively Impact 45 THIRD QUARTER HIGHLIGHTS 45 Earned 45 Has Received 45 Be Tested 45 Asset Impairment Charge 45 Phase III Trials 45 Proves Successful 45 Treated Patients 45 Results Exceed Expectations 45 Compensated 45 Remains Elusive 45 Differentiates 45 Double Digit Growth 45 Bottomed Out 45 Diminish 45 Net Profit Drops 45 Versus Placebo 45 Mechel Announces 45 Achieves Significant 45 Posts Highest 45 Impair 45 Spectrum Pharmaceuticals Announces 45 Improve Quality 45 Helps Boost 45 Increased Productivity 45 Study Showed 45 Sales Surpass 45 Progresses 45 Highlights Include 45 Surge Lifts 45 achieving 45 Remained 45 Provides 45 Portend 45 Substantially Improved 45 Face Transplant 45 Achieves Record Growth 45 Adverse Outcomes 45 Develop 45 Hits Milestone 45 Expedites 45 Boasts Record 45 More Than Doubles 45 Pays Off 45 Being Studied 45 Re Affirms 45 Loss Widened 45 Plummeted 45 Utilized 45 Contracts Totaling 45 Deteriorates 45 Translates Into 45 Broadened 45 Robust Growth 45 Adversely Affects 45 Validates 45 Be Treated 45 Receives 45 Enhance 45 Sequential Quarter 45 Dramatic Improvements 45 Revised Upward 45 Demonstrates 45 Respiratory Symptoms 45 Slight Improvement 45 SABESP Announces 45 Sights Set 45 Posts Record 45 Appears Safe 45 Successfully Completed 45 Improve Productivity 45 Slower Than Expected 45 Further Validates 45 Generate 45 Strengthens Balance Sheet 45 Sets Record 45 Varies Widely 45 Milestone Payment 45 Paying Off 45 Accurately Predict 45 Eluded 45 Study Confirms 45 Rate Declines 45 Per Cent Growth 45 MNOK #,# 45 Prolongs 44 Viable Alternative 44 Prolongs Life 44 Lies Ahead 44 Highest Levels 44 Surgical Procedures 44 Sequentially 44 Fold Increase 44 Dramatically Increase 44 Improved Outcomes 44 Maintains 44 Nears Completion 44 Trend Continues 44 Rate Climbs 44 Notches 44 Remains Steady 44 Proves Effective 44 Target Lesion Revascularization TLR 44 Cuts Costs 44 Final Stages 44 Stabilizes 44 Distinguishes 44 Maintain 44 Gained 44 Improve Efficiency 44 Significantly Improves 44 Effectively Manage 44 Accelerates Growth 44 Eighth Consecutive 44 Viral Suppression 44 Rises Sharply 44 Grows 44 Moves Towards 44 Randomized Trials 44 Multi Billion Dollar 44 Propels 44 Percent Increase 44 Demonstrates Long Term 44 Substantially Increase 44 Hard Earned 44 Could Exceed 44 Profits Climb 44 Significant Reductions 44 Without Sacrificing 44 Amounted 44 Reaps 44 Below Expectations 44 Maintains Strong 44 Largest Single 44 Efficacy Trial 44 Lowest Level 44 Highest Ranking 44 Initiates Clinical Trials 44 Reaches Highest 44 Patient Enrollment 44 Remain Strong 44 Sees 44 Brigham Exploration Announces 44 Sequential Increase 44 Generating Electricity 44 TOP Ships Announces 44 Viable Option 44 Is Better Than 44 Flamel Technologies Announces 44 Report Analyzes 44 Manages 44 Lower Than Expected 44 Shows Promise 44 Pursue 44 Forges Ahead 44 Be Delayed 44 Is Easier Than 44 Mortgage Rates Jump 44 Sixth Consecutive Quarter 44 Completes 44 ROCA Reports 44 Holds 44 ESCO Announces 44 Revenues Exceed 44 Attain 44 CGGVeritas Announces 44 Largest Amount 44 Highest Priority 44 #compared 44 Incurred 44 Percent Annually 44 Dips Slightly 44 Sees Decline 44 Declared 44 Summarizes 44 Expands Scope 44 Declines Slightly 44 AMSC Receives 44 Has Declined 44 Significantly Reduce 44 WebTech Wireless Announces 44 Exceed Guidance 44 Equals 44 Reduces Risk 44 Proves 44 comparedto 44 Bizjet 44 Reaches Milestone 44 Be Evaluated 44 Reflects 44 Enables 44 Increase Efficiency 44 Wholly Owned 44 Dramatically Improves 44 Exceeding Expectations 44 Dispute Resolved 44 Remain Steady 44 Steep Rise 44 Slower Than 44 Stepped Up 44 Blood Pressure Reduction 44 Remains Unchanged 43 Safer Than 43 Data Suggest 43 Outsold 43 Smaller Than 43 Benefited From 43 Goodwill Impairment Charge 43 CorVel Announces 43 Boosts Survival 43 Can Predict 43 Recertified 43 Challenges Remain 43 Verifies 43 Expense Expense 43 Milestone Achieved 43 Improve Profitability 43 Saved Lives 43 Underpins 43 Be Studied 43 Demonstrates Positive 43 Better Outcomes 43 Reports Positive 43 Remain Intact 43 Has Been Made 43 Fourth Consecutive Quarter 43 Converted Into 43 PremierWest Bancorp Announces 43 Encision Reports 43 Remain Robust 43 Larger Than 43 Diminishes 43 Assures 43 Expects FY# 43 Entered Orders 43 Main Outcome Measures 43 Boost Efficiency 43 Rheumatoid Arthritis Patients 43 Boosts Productivity 43 Finds Success 43 Retention Rates 43 Rate Jumps 43 Kidney Function 43 Who Underwent 43 Viral Load 43 Significant Improvement 43 Shipped 43 Promote 43 Occur 43 Loss Narrowed 43 Receives Initial 43 Double Digit Earnings 43 Repositions 43 Foresees 43 Reduces 43 Equates 43 Proven Effective 43 Multiple Myeloma Patients 43 Growth Trajectory 43 Boosts 43 FLIR Systems Announces 43 CECO Environmental Announces 43 Fewer Side Effects 43 Move Closer 43 Income Rises 43 BPZ Energy Announces 43 Stereotaxis Announces 43 Survival Rates 43 Delivers Strong 43 Faring Better Than 43 Risks Remain 43 Longer Than 43 Agreement Reached 43 Reinforces 43 Decision Delayed 43 Percent Reduction 43 Could Spell 43 Anticipated 43 Ranked Highest 43 Achieves Unprecedented 43 Passes Milestone 43 Pays 43 Critical Component 43 Sets Goal 43 Reveals Significant 43 More Than 43 Up Sharply 43 Lose Sight 43 Quantifies 43 Says ABI Research 43 Successfully Complete 43 Experts Urge 43 Sees Rise 43 Claimed 43 Entered 43 Be Implemented 43 Grants Awarded 43 Randomized Placebo Controlled Trial 43 Successfully Completes 43 Growth Spurt 43 Dipping Into 43 Tread Carefully 43 Metastatic Renal Cell Carcinoma 43 Achieves Record Production 43 Randomized Clinical Trial 43 Realises 43 Early Stages 43 Fully Prepared 43 Feasible 43 Success Depends 43 Study Shows 43 Maximise 43 Important Than 43 Hole Drilled 43 Ableauctions Announces 43 Step Towards 43 Sees Positive 43 eLoyalty Announces 43 Marks Milestone 43 Adversely Affect 43 Slight Increase 43 ViaSat Receives 43 Evaporates 43 Reduces Debt 43 Fulfilled 43 Shatters 43 Revenues Grew 43 Leads 43 Posts Impressive 43 Phase IIb Trial 43 Phase IIb Clinical Trial 43 MAG Silver Reports 43 Readily Available 43 Obtains 43 Helps Reduce 43 Azure Dynamics Announces 43 Excellon Announces 43 Go Unnoticed 43 Needed 43 Repaid 43 Left Atrial 43 Important Milestone 43 Achieves Record Results 43 Qrtr 43 Reconfirms 43 Weapons Caches 43 Help Reduce 43 Unusual Items 43 Has Been Awarded 43 Productivity Rises 43 Shows Efficacy 43 KEMET Announces 43 Rises Slightly 43 Purchasing Decisions 43 Single Dose 43 Expects 43 Ramco Gershenson Announces 43 Appreciable 43 Hoped 43 Keeps Growing 43 Decreases 43 Scaled Back 43 * [021] 43 Lowest Rate 43 Report Indicates 43 Improve Outcomes 43 Attracts Record 43 Outstrips 43 Xenonics Announces 43 Recognises 43 Operational Improvements 43 Exceed Estimates 43 anincrease 43 Percent Jump 43 Signifies 43 Reaffirms 43 Nordson Corporation Declares 43 Builds 43 Remains Strong 43 Provide 43 Ozone Levels 43 Amasses 43 Steady Decline 43 Sono Tek Announces 43 43 Profit Surged 43 Accommodate 43 Fifth Consecutive Year 42 Finally Arrived 42 Levels Linked 42 Shapes Up 42 Hits Lowest Level 42 Meets Expectations 42 Record Third Quarter 42 ascompared 42 Underpin 42 HemaCare Reports 42 Recieves 42 Face Dilemma 42 Restrains 42 Trickles Down 42 Interoperate 42 Raises Hopes 42 Fewer Than 42 Conclude 42 Create Enduring 42 Growing Rapidly 42 Sees Dramatic 42 Billion Spent 42 Has Grown 42 Increased Profitability 42 Earns Highest 42 Step Toward 42 Secures Additional 42 Dramatically Reduced 42 Celebrates Successful 42 Eludes 42 Soared 42 Strives 42 Increases 42 Contract Renewals 42 Offing 42 Reduce Expenses 42 Climbed 42 Receive Milestone Payment 42 Result 42 Useful Tool 42 Diagnostic Tools 42 Gastar Exploration Announces 42 Maximized 42 Increases Quarterly 42 Zynex Announces 42 Debate Grows 42 Creeps Up 42 Ensures 42 Maintains Momentum 42 Depreciate 42 Concerns Remain 42 Awarded Contracts 42 Reduce Costs 42 Negotiates 42 Pose Threat 42 FDA Okays 42 Fully Operational 42 EnerTeck Corporation Announces 42 Maximize Productivity 42 Cuts Update2 42 Lay Groundwork 42 Dramatically Reduce 42 Far Exceeds 42 Profit Skyrockets 42 Net Loss Narrows 42 Deaths Caused 42 Improve Survival 42 Poses Risk 42 Report Reveals 42 Secondary Endpoints 42 NDA Submission 42 Cost Reductions 42 Restricts Access 42 Demonstrates Superior 42 Richer Than 42 Consolidated EBITDA Margin 42 Improved Margins 42 Achieves Record Breaking 42 Invested 42 Showed Significant 42 Proven Techniques 42 Ranks Number 42 Kidney Transplants 42 Award Recognizes 42 Greatly Improve 42 Tremendous Growth 42 Lymph Nodes 42 Hits Record 42 Plays Role 42 Involves 42 More Efficiently 42 Carries Out 42 Sequential Quarterly 42 Doubts Remain 42 Cost Savings 42 Help Improve 42 Exemplify 42 Too Expensive 42 Looks Toward 42 Nine Month 42 Urine Test 42 EBITD 42 Better Manage 42 Decline Quick Facts 42 Deserve 42 Largest Ever 42 Segment Highlights 42 Extends 42 Growth Slowest 42 Rapidly Growing 42 Sees FY# 42 Have Doubled 42 Manage 42 Hauls 42 Owes Him 42 Less Than Estimated 42 Moral Obligation 42 Remains Confident 42 Lowering Costs 42 Expensive Than 42 Report Finds 42 Consecutive Years 42 Competition Intensifies 42 Increase Dramatically 42 Doctor Sentenced 42 Captures 42 Sixth Consecutive 42 Successful Implementation 42 Actively Seeking 42 Triple Digit Growth 42 Worsens 42 Different Paths 42 XPEL Announces 42 Establish 42 Reports Fourth Consecutive 42 #Table [003] 42 Impaired Loans 42 Churns Out 42 Nymox Reports 42 Could Save Lives 42 Second Consecutive 42 Chemotherapy Improves 42 Calculates 42 Could Revolutionize 42 Govt Mulls 42 Walks Away 42 Immune Cells 42 Profits Decline 42 Recieve 42 Accenture Study Finds 42 EUR#.# Billion [003] 42 Correlation Between 42 Has Doubled 42 Will Overtake 42 Becomes Reality 42 Files Patent Application 42 Poniard Pharmaceuticals Announces 42 Re Opened 42 Achieve Breakthrough 42 Dramatically Improve 42 Positions Itself 42 Have Suffered 42 Accomplish 42 Margin Expansion 42 Commence Immediately 42 Ramping Up 42 Accomplishments 42 Record Second Quarter 42 Showing Signs 42 Greatly Improves 42 Held Steady 42 Faster Than 42 Lowest Ever 42 Positive Results 42 Optimizes 42 Poses Risks 42 Highest 42 Widely Available 42 Rapid Expansion 42 Negatively Impacted 42 Averts 42 Delayed Again 42 Pivotal Study 42 Negative Effects 42 Mistakes Made 42 Contemplated 42 Superior Customer Experience 42 Commercializes 42 Expend 42 Operating Expense Ratio 42 EHR Adoption 42 Testing Finds 42 Poorly Controlled 42 Upward Trend 42 Bloodstream Infections 42 Cost Structure 42 Fall Sharply 42 Important Role 42 Margin Improvement 42 Steep Decline 42 Help Diagnose 42 Progress Toward 42 Oversaw 42 Past Decade 42 Drug Fails 42 Wage Increases 42 Applies 42 Obtains Financing 42 Helps Identify 42 Non Inferiority 42 Genetic Tests 42 Sales Soar 42 Improve Customer Satisfaction 42 Has Passed 42 Refines 42 Rise Sharply 42 Be Removed 42 noninterest expense divided 42 Scientists Develop 42 Reinforce 42 Blocked Arteries 42 Demonstrates Commitment 42 Completes Successful 42 Figured Out 42 -Soft soled shoes 42 meaningful ORACLE CORPORATION 42 Incr 42 Double Digit 42 Holds Steady 42 Qualify 42 Publicizes 42 EUR1 Billion 42 Adversely Affected 42 Devalues 42 Upheld 42 Bladex Announces 42 Retakes 42 Tumor Cells 42 Has Been 42 Guidelines Issued 42 Exceeding 42 Dwindles 42 Confirms Commitment 42 Awaits 42 Being Evaluated 42 Recognized 42 Technological Advances 42 Present Preclinical Data 42 Could Prove 42 Main Outcome Measure 42 Mitigates 42 Undermine 42 Treating Depression 42 Quantify 42 Drop Sharply 42 Diversifies 42 Occupies 42 Contract Signings 41 Sequential Revenue 41 Awarded Patent 41 Operating Efficiencies 41 Unmet Need 41 Reach Highest Level 41 Accepted Into 41 Puts Emphasis 41 Announces 41 Less Invasive 41 Resolve Dispute Over 41 Fast Growing 41 Positively Impacts 41 #/Oz 41 Help Detect 41 VIVUS Announces 41 Proven 41 Profit Grows 41 Outperforms 41 Billion Invested 41 Detecting Breast Cancer 41 Hit Highest Level 41 Has Entered 41 Half Billion Dollars 41 SulphCo Announces 41 Pulls Off 41 IrelandRESEARCH AND MARKETS 41 Will Remain 41 Succeeds 41 Growing Faster Than 41 Opens Door 41 Quantifiable 41 Achieve Maximum 41 Remain Stable 41 Largely Unchanged 41 Insures 41 Soars 41 Profit Fell 41 Improved Profitability 41 Gaps Remain 41 XIENCE V. 41 ER Visits 41 Extends Term 41 Risked 41 Feds Approve 41 Increase Efficiencies 41 Fourth Consecutive 41 Experts Predict 41 Outpaces 41 Enrich Uranium 41 Growth Accelerates 41 Reclassifies 41 Affirms Commitment 41 Could Trigger 41 Earn Less Than 41 Submits Application 41 Procures 41 Curtiss Wright Awarded 41 Decade Ago 41 Paying Dividends 41 PowerSecure Announces 41 CPI Aerostructures Announces 41 Stunted Growth 41 Urgent Need 41 FY# FY# FY# FY# [002] 41 Commited 41 Receives Highest 41 Prestigious List 41 Profitable Growth 41 Commercialize 41 Signs Agreements 41 Operates 41 Concerns Raised 41 Guides FY# 41 Posts Strong 41 Could Mean 41 Genetic Defect 41 nizatidine 41 Would Have Been 41 Productivity Gains 41 Brain Metastases 41 Alleged Rape 41 Huge Success 41 Riskier Than 41 Patents Issued 41 Burglars Steal 41 Went Missing 41 Help Manage 41 Pivotal Trials 41 Comorbidities 41 Can Be Avoided 41 Issues Guidance 41 Becomes 41 Million Annually 41 Be Monitored 41 Slightly Lower 41 Leadership Position 41 Study Shows Benefits 41 Updates Guidance 41 Lags Behind 41 Minimize Risk 41 Has Become 41 Widest 41 Revolutionizes 41 Prevents 41 Strongly Linked 41 Had Been 41 Demonstrates Ability 41 Ease Pain 41 Gets Tougher 41 Lighter Than 41 Momentum Builds 41 Symposium Focuses 41 Offers Unprecedented 41 Relieves 41 Pretax Income 41 Mortgage Modifications 41 Costs Rise 41 Fortifies 41 Accenture Survey Finds 41 Envoy Says 41 Breast Tumor 41 Benefits Outweigh 41 Report Identifies 41 Proved Reserve 41 Occurs 41 - REVENUES [002] 41 Testosterone Patch 41 Successfully Delivers 41 Streak Continues 41 Could Prove Costly 41 Opens Doors 41 Inhaled Corticosteroids 41 Cholesterol Drugs 41 Profits Soar 41 DXP Enterprises Announces 41 Underlie 41 Owns 41 Spending Rises 41 Gets 41 Grow Faster Than 41 Lowers Costs 41 Writes Off 41 Various Types 41 Remains Stable 41 Deloitte commends 41 Physical Function 41 Existed 41 Losses Narrow 41 Enjoys Record 41 Report Examines 41 Possesion 41 Reclaims 41 Device Helps 41 Malaria Vaccine 41 Worse Than Expected 41 Antibiotic Therapy 41 Dries Up 41 Executes 41 LifeVantage Announces 41 Be Resolved 41 Eye Exams 41 Poses Threat 41 Increases Risk 41 Improves Patient 41 Sees Increase 41 Sustained Growth 41 Boost Output 41 Provides Guidance 41 Restates 41 Experts Advise 41 Has Tripled 41 CareerBuilder.com Survey Finds 41 Who Faked 41 FFO Per Share 41 Participated 41 BioElectronics Announces 41 Weaker Than 41 Smartphone Shipments 41 Differs 41 Third Consecutive Year 41 Meet Stringent 41 Biggest Threat 41 Have Been 41 Ayoon Wa Azan 41 Receives Patent 41 Milestone Payments 41 Restructuring Charge 41 Confirm 41 Successful Launch 41 Unstable Angina Patients Suppress 41 Looms Large 41 Non Responders 41 Barrels Per Day 41 Output Fell 41 Be Phased 41 Wiped Out